Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

Pertrochanteric and Subtrochanteric Femur Fractures Clinical Trial

Official title:

Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00367406
• Other study ID #: 2006/280
• Status: Completed
• Phase: N/A
• Start date: November 2006
• Est. completion date: July 2015

Study information

• Verified date: December 2014
• Source: University Hospital, Ghent
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pertrochanteric and subtrochanteric femur fractures will be treated with a Gamma 3 nail or an ACE Trochanteric nail.

Following topics will be assessed: fracture consolidation, mobility, pain, walking power, agility.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: July 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Pertrochanteric or subtrochanteric femur fracture

Related Conditions & MeSH terms

• Femoral Fractures
• Pertrochanteric and Subtrochanteric Femur Fractures

Intervention

Device:
• Gamma 3 nail versus ACE trochanteric nail
Comparing Gamma 3 nail versus ACE trochanteric nail

Locations

Country	Name	City	State
Belgium	University Hospital Ghent	Ghent

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Consolidation of the fracture		From surgery untill healing

External Links

•   Website University Hospital Ghent